Literature DB >> 28254589

Excessive tau accumulation in the parieto-occipital cortex characterizes early-onset Alzheimer's disease.

Hanna Cho1, Jae Yong Choi2, Seung Ha Lee1, Jae Hoon Lee2, Young-Chul Choi1, Young Hoon Ryu2, Myoung Sik Lee1, Chul Hyoung Lyoo3.   

Abstract

Early-onset Alzheimer's disease (EOAD) is characterized by greater nonmemory dysfunctions, more rapid progression, and greater hypometabolism and atrophy than late-onset AD (LOAD). We sought to investigate the differences in tau accumulation patterns between early- and late-onset patients with AD and mild cognitive impairment (MCI). In 90 patients who completed 18F-AV-1451 and 18F-florbetaben positron emission tomography scans, only 59 amyloid-positive patients (11 EOAD, 10 EOMCI, 21 LOAD, and 17 LOMCI) were included in this study. We compared cortical 18F-AV-1451 binding between each patient group and corresponding amyloid-negative age-matched controls. In contrast to no difference in cortical binding between the EOMCI and LOMCI groups, EOAD showed greater binding in the parieto-occipital cortex than LOAD. The parieto-occipital binding correlated with visuospatial dysfunction in the EOAD spectrum, whereas binding in the temporal cortex correlated with verbal memory dysfunction in the LOAD spectrum. Our findings suggest that distinct topographic distribution of tau may influence the nature of cognitive impairment in EOAD patients.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Early onset; Mild cognitive impairment; Positron emission tomography; Tau

Mesh:

Substances:

Year:  2017        PMID: 28254589     DOI: 10.1016/j.neurobiolaging.2017.01.024

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  32 in total

1.  Progressive Tau Accumulation in Alzheimer Disease: 2-Year Follow-up Study.

Authors:  Hanna Cho; Jae Yong Choi; Hye Sun Lee; Jae Hoon Lee; Young Hoon Ryu; Myung Sik Lee; Clifford R Jack; Chul Hyoung Lyoo
Journal:  J Nucl Med       Date:  2019-03-29       Impact factor: 10.057

2.  The role of age on tau PET uptake and gray matter atrophy in atypical Alzheimer's disease.

Authors:  Jennifer L Whitwell; Peter Martin; Jonathan Graff-Radford; Mary M Machulda; Matthew L Senjem; Christopher G Schwarz; Stephen D Weigand; Anthony J Spychalla; Daniel A Drubach; Clifford R Jack; Val J Lowe; Keith A Josephs
Journal:  Alzheimers Dement       Date:  2019-03-08       Impact factor: 21.566

3.  Three-year changes of cortical 18F-FDG in amnestic vs. non-amnestic sporadic early-onset Alzheimer's disease.

Authors:  Matthieu Vanhoutte; Franck Semah; Xavier Leclerc; Adeline Rollin Sillaire; Alice Jaillard; Grégory Kuchcinski; Xavier Delbeuck; Rachid Fahmi; Florence Pasquier; Renaud Lopes
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-10-12       Impact factor: 9.236

4.  Effect Modifiers of TDP-43-Associated Hippocampal Atrophy Rates in Patients with Alzheimer's Disease Neuropathological Changes.

Authors:  Marina Buciuc; Alexandra M Wennberg; Stephen D Weigand; Melissa E Murray; Matthew L Senjem; Anthony J Spychalla; Bradley F Boeve; David S Knopman; Clifford R Jack; Kejal Kantarci; Joseph E Parisi; Dennis W Dickson; Ronald C Petersen; Jennifer L Whitwell; Keith A Josephs
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

5.  Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers.

Authors:  Brian A Gordon; Tyler M Blazey; Jon Christensen; Aylin Dincer; Shaney Flores; Sarah Keefe; Charles Chen; Yi Su; Eric M McDade; Guoqiao Wang; Yan Li; Jason Hassenstab; Andrew Aschenbrenner; Russ Hornbeck; Clifford R Jack; Beau M Ances; Sarah B Berman; Jared R Brosch; Douglas Galasko; Serge Gauthier; James J Lah; Mario Masellis; Christopher H van Dyck; Mark A Mintun; Gregory Klein; Smiljana Ristic; Nigel J Cairns; Daniel S Marcus; Chengjie Xiong; David M Holtzman; Marcus E Raichle; John C Morris; Randall J Bateman; Tammie L S Benzinger
Journal:  Brain       Date:  2019-04-01       Impact factor: 13.501

Review 6.  Early-onset Alzheimer Disease and Its Variants.

Authors:  Mario F Mendez
Journal:  Continuum (Minneap Minn)       Date:  2019-02

7.  Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer's disease.

Authors:  Jennifer L Whitwell; Jonathan Graff-Radford; Nirubol Tosakulwong; Stephen D Weigand; Mary M Machulda; Matthew L Senjem; Anthony J Spychalla; Prashanthi Vemuri; David T Jones; Daniel A Drubach; David S Knopman; Bradley F Boeve; Nilüfer Ertekin-Taner; Ronald C Petersen; Val J Lowe; Clifford R Jack; Keith A Josephs
Journal:  Alzheimers Dement       Date:  2018-03-30       Impact factor: 21.566

8.  Regional Distribution, Asymmetry, and Clinical Correlates of Tau Uptake on [18F]AV-1451 PET in Atypical Alzheimer's Disease.

Authors:  Katerina A Tetzloff; Jonathan Graff-Radford; Peter R Martin; Nirubol Tosakulwong; Mary M Machulda; Joseph R Duffy; Heather M Clark; Matthew L Senjem; Christopher G Schwarz; Anthony J Spychalla; Daniel A Drubach; Clifford R Jack; Val J Lowe; Keith A Josephs; Jennifer L Whitwell
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

9.  Tau PET imaging predicts cognition in atypical variants of Alzheimer's disease.

Authors:  Jeffrey S Phillips; Sandhitsu R Das; Corey T McMillan; David J Irwin; Emily E Roll; Fulvio Da Re; Ilya M Nasrallah; David A Wolk; Murray Grossman
Journal:  Hum Brain Mapp       Date:  2017-11-06       Impact factor: 5.038

10.  Data-driven approaches for tau-PET imaging biomarkers in Alzheimer's disease.

Authors:  Jacob W Vogel; Niklas Mattsson; Yasser Iturria-Medina; Olof T Strandberg; Michael Schöll; Christian Dansereau; Sylvia Villeneuve; Wiesje M van der Flier; Philip Scheltens; Pierre Bellec; Alan C Evans; Oskar Hansson; Rik Ossenkoppele
Journal:  Hum Brain Mapp       Date:  2018-10-19       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.